United States
Germany
Japan
United Kingdom
China
MAPK3 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Products
MAPK3 (ERK1) mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
MAPK3 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
MAPK3 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 3
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Recombinant protein of human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
CNY 3,990.00
2周
CNY 3,990.00
2周
MAPK3 (ERK1) mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
MAPK3 (tGFP-tagged) - Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
MAPK3 (tGFP-tagged) - Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
MAPK3 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Recombinant protein of human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Conjugates
Modifications
Clonalities
Mutants
Assay Types
QC Levels
Pathways
- Acute myeloid leukemia (52)
- Adherens junction (52)
- Alzheimer's disease (52)
- Axon guidance (52)
- B cell receptor signaling pathway (52)
- Bladder cancer (52)
- Chemokine signaling pathway (52)
- Chronic myeloid leukemia (52)
- Colorectal cancer (52)
- Dorso-ventral axis formation (52)
- Endometrial cancer (52)
- ErbB signaling pathway (52)
- Fc epsilon RI signaling pathway (52)
- Fc gamma R-mediated phagocytosis (52)
- Focal adhesion (52)
- Gap junction (52)
- Glioma (52)
- GnRH signaling pathway (52)
- Insulin signaling pathway (52)
- Long-term depression (52)
- Long-term potentiation (52)
- MAPK signaling pathway (52)
- Melanogenesis (52)
- Melanoma (52)
- NOD-like receptor signaling pathway (52)
- Natural killer cell mediated cytotoxicity (52)
- Neurotrophin signaling pathway (52)
- Non-small cell lung cancer (52)
- Oocyte meiosis (52)
- Pancreatic cancer (52)
- Pathways in cancer (52)
- Prion diseases (52)
- Progesterone-mediated oocyte maturation (52)
- Prostate cancer (52)
- Regulation of actin cytoskeleton (52)
- Renal cell carcinoma (52)
- T cell receptor signaling pathway (52)
- TGF-beta signaling pathway (52)
- Thyroid cancer (52)
- Toll-like receptor signaling pathway (52)
- Type II diabetes mellitus (52)
- VEGF signaling pathway (52)
- Vascular smooth muscle contraction (52)
- mTOR signaling pathway (52)
